Fröhlich, Hanna
Frey, Norbert
Estler, Bent
Mäck, Mirjam
Schlegel, Philipp
Beckendorf, Jan
Frankenstein, Lutz
Täger, Tobias
Funding for this research was provided by:
Novartis Pharma
Universitätsklinikum Heidelberg
Article History
Accepted: 15 August 2022
First Online: 22 September 2022
Declarations
:
: This study was funded by Novartis Pharma GmbH, Nürnberg, Germany. The sponsor was involved in the design of the study and approved the submission of the present article for publication. Data collection, analysis and interpretation as well as writing of the report were solely performed by the authors of the present article.
: Hanna Fröhlich, Norbert Frey, Bent Estler, Mirjam Mäck, Philipp Schlegel, Jan Beckendorf, Lutz Frankenstein and Tobias Täger declare that they have no potential conflicts of interest that might be relevant to the contents of this article.
: All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by HF, LF and TT. The first draft of the manuscript was written by HF and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of University of Heidelberg.
: Informed consent was obtained from all individual participants included in the study.
: Not applicable.
: The datasets analysed during the current study are available from the corresponding author on reasonable request.
: Not applicable.